What is the appropriate Augmentin (amoxicillin/clavulanate) dose for a child weighing 71 lb (≈ 32 kg)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin Dosing for a 71-Pound Child

For a child weighing 71 pounds (32 kg), the standard Augmentin dose is 45 mg/kg/day of the amoxicillin component divided into two doses (approximately 720 mg twice daily), or 90 mg/kg/day divided into two doses (approximately 1,440 mg twice daily) for severe infections or high-risk situations. 1

Weight-Based Calculation

  • A 71-pound child weighs approximately 32 kg 1
  • Standard-dose regimen: 45 mg/kg/day = 1,440 mg total daily (720 mg twice daily) 1
  • High-dose regimen: 90 mg/kg/day = 2,880 mg total daily (1,440 mg twice daily) 1
  • Using a 400 mg/5 mL suspension, the standard dose equals approximately 9 mL twice daily, while the high dose equals approximately 18 mL twice daily 1

When to Use Standard vs High-Dose Regimen

Standard Dose (45 mg/kg/day) Indications

  • Children ≥2 years with uncomplicated respiratory infections and no recent antibiotic exposure 1
  • Acute bacterial sinusitis in children ≥2 years who do not attend daycare and have not received antibiotics in the past 4 weeks 1
  • Mild to moderate infections without risk factors for resistant organisms 1

High Dose (90 mg/kg/day) Indications

Use the high-dose regimen when ANY of the following risk factors are present: 1, 2

  • Age <2 years 1
  • Daycare attendance 1
  • Recent antibiotic use (within the past 30 days) 1
  • Geographic area with >10% penicillin-resistant Streptococcus pneumoniae 1
  • Moderate-to-severe illness at presentation 1
  • Community-acquired pneumonia 1
  • Incomplete Haemophilus influenzae type b vaccination 2
  • Concurrent purulent acute otitis media 2

Specific Infection Dosing

Acute Otitis Media

  • High-dose regimen: 90 mg/kg/day (1,440 mg twice daily) for 10 days 2
  • This dosing achieves middle ear fluid concentrations adequate to overcome penicillin-resistant S. pneumoniae 2

Community-Acquired Pneumonia

  • High-dose regimen: 90 mg/kg/day (1,440 mg twice daily) for 10 days 1, 2
  • This applies to both children <5 years and ≥5 years with presumed bacterial pneumonia 1

Acute Bacterial Sinusitis

  • Standard dose (45 mg/kg/day) for children ≥2 years without risk factors 1
  • High dose (90 mg/kg/day) for children <2 years, daycare attendees, or recent antibiotic use 1
  • Continue for 7 days after symptom resolution, with a minimum total of 10 days 1

Maximum Dosing Limits

  • Maximum single dose: 2,000 mg per administration regardless of weight 2
  • Maximum daily dose: 4,000 mg per day of the amoxicillin component 1
  • For a 32 kg child, even the high-dose regimen (2,880 mg/day) remains well below these maximum limits 1

Treatment Duration and Monitoring

  • Most respiratory infections require a 10-day course 1, 2
  • Continue therapy for at least 48-72 hours after complete resolution of symptoms 1
  • Clinical improvement should be evident within 48-72 hours of starting appropriate therapy 1, 2
  • If no improvement occurs within 48-72 hours, reevaluate and consider atypical pathogens or complications 1

Administration Guidelines

  • Augmentin may be taken without regard to meals, but absorption of clavulanate is enhanced when taken at the start of a meal 3
  • To minimize gastrointestinal intolerance, administer at the start of meals 3
  • The high-dose formulation provides a 14:1 ratio of amoxicillin to clavulanate, which minimizes diarrhea compared to other ratios 2

Common Pitfalls to Avoid

  • Do not use twice-daily dosing of standard formulations for pneumonia—the high-dose twice-daily regimen is specifically required 1
  • Do not substitute two 250 mg tablets for one 500 mg tablet—they contain different amounts of clavulanic acid and are not equivalent 3
  • Do not underdose—using standard doses when high-dose therapy is indicated leads to treatment failure with resistant organisms 2
  • Do not prescribe for viral infections—most upper respiratory infections are viral and do not benefit from antibiotics 2
  • Verify the suspension concentration (125/31,250/62, or 400/57 mg per 5 mL) before calculating volume to avoid dosing errors 2

References

Guideline

Amoxicillin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Amoxicillin-Clavulanate Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What volume in mL of the standard 400 mg/57 mg amoxicillin‑clavulanate oral suspension should be given every 12 hours for a 5‑kg child for a 10‑day course?
What is the appropriate Augmentin (amoxicillin‑clavulanate) dosing regimen for a child weighing 18.2 kg with normal renal function and no penicillin allergy?
What is the correct dose of Augmentin (amoxicillin/clavulanate) 250 mg/5 mL suspension for a 6.58 kg infant?
How should amoxicillin‑clavulanate potassium 625 mg be dosed in adults and children, and what are its indications, contraindications, renal dose adjustments, and alternative therapies?
In a 76-year-old man three days after a grinder injury with a red, throbbing distal phalanx and several subcutaneous pus collections, is treatment with oral amoxicillin-clavulanate and scheduling hand‑surgeon review the next day sufficient?
What is the recommended dosing schedule, duration, storage, and contact‑lens handling for Ofloxacin 0.3% ophthalmic solution eye drops?
What are the appropriate pharmacologic treatment options for a patient with primary insomnia and no contraindicating medical conditions?
What are the eligibility criteria for CardioMEMS pulmonary‑artery pressure sensor implantation in adult (≥ 18 years) heart‑failure patients with New York Heart Association class III symptoms despite guideline‑directed medical therapy (including an ACE inhibitor or angiotensin‑receptor blocker or angiotensin‑receptor‑neprilysin inhibitor, a beta‑blocker, and a mineralocorticoid‑receptor antagonist unless contraindicated), who have had at least one heart‑failure hospitalization or emergency‑department visit for worsening heart failure in the past 12 months, regardless of left‑ventricular ejection fraction, who have suitable pulmonary‑artery anatomy (mean pulmonary‑artery pressure ≤ 35 mm Hg, no severe pulmonary hypertension, no right‑ventricular outflow obstruction, and no recent pulmonary‑artery interventions), and who have no contraindications such as active systemic infection, uncontrolled coagulopathy, recent major bleeding, end‑stage renal disease requiring dialysis, or inability to perform daily remote transmissions (e.g., severe cognitive impairment, lack of compatible home Wi‑Fi or cellular connection, or inability to operate the handheld device), and who are able and willing to adhere to daily transmission, attend follow‑up visits, and cooperate with the multidisciplinary heart‑failure team?
Should antiplatelet therapy be initiated in a 24‑year‑old asymptomatic male with HIV infection and borderline‑high low‑density lipoprotein cholesterol but low 10‑year atherosclerotic cardiovascular disease risk?
Can a patient who had a normal low‑dose chest CT five months ago still be eligible for annual lung‑cancer screening in Ontario?
Which specialist should manage a sebaceous (epidermoid) cyst on the right hip?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.